Levels of Serum Soluble P-Selectin and E-Selectin in Psoriatıc Patients

Vol. 26 No. 2, 2014 275 Received January 3, 2013, Revised April 6, 2013, Accepted for publication May 14, 2013 *Recep Kesli is now with Department of Microbiology, Afyon University Faculty of Medicine, Afyonkarahisar, Turkey. Corresponding author: Arzu Ataseven, Department of Dermatology, Konya Training and Research Hospital, Meram, Konya 42090, Turkey. Tel: 90-0 505 691 58 59, Fax: 90-0 332 323 67 23, E-mail: arzuataseven@hotmail. com This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. 5. Pasqualotto AC, Bittencourt Severo C, de Mattos Oliveira F, Severo LC. Cryptococcemia. An analysis of 28 cases with emphasis on the clinical outcome and its etiologic agent. Rev Iberoam Micol 2004;21:143-146.

[1]  F. Diamantino,et al.  [Future perspectives in the treatment of psoriasis: news in biological therapies]. , 2011, Acta medica portuguesa.

[2]  R. Tamagawa‐Mineoka,et al.  Platelet activation in patients with psoriasis: increased plasma levels of platelet-derived microparticles and soluble P-selectin. , 2010, Journal of the American Academy of Dermatology.

[3]  Wolf-Henning Boehncke,et al.  Platelet P‐selectin reflects a state of cutaneous inflammation: possible application to monitor treatment efficacy in psoriasis , 2009, Experimental dermatology.

[4]  H. Mahdi,et al.  Soluble E-selectin and P-Selectin Serum Levels in Patients with Psoriasis Compared to Healthy Controls , 2010 .

[5]  M. Schön.  Inhibitors of selectin functions in the treatment of inflammatory skin disorders , 2005, Therapeutics and clinical risk management.

[6]  C. Griffiths,et al.  Anti‐E‐selectin is ineffective in the treatment of psoriasis: a randomized trial , 2002, The British journal of dermatology.

[7]  A. Kapp,et al.  Soluble E‐selectin in sera of patients with atopic dermatitis and psoriasis—correlation with disease activity , 1996, The British journal of dermatology.

[8]  R W Groves,et al.  Detection of circulating adhesion molecules in erythrodermic skin disease. , 1995, Journal of the American Academy of Dermatology.

[9]  Franco Ameglio,et al.  Soluble E-selectin and soluble tumour necrosis factor receptor (60 kD) serum levels in patients with psoriasis. , 1995, Dermatology.

[10]  H. Wakita,et al.  E-selectin and vascular cell adhesion molecule-1 are critical for initial trafficking of helper-inducer/memory T cells in psoriatic plaques. , 1994, Archives of dermatology.